Blue California Commercializes Nicotinamide Mononucleotide (NMN) for Supporting an Increased Healthspan
A better cost-effective option is now available for dietary supplement, functional food, and beverage manufacturers.
Rancho Santa Margarita, Calif., July 20, 2021 (GLOBE NEWSWIRE) -- Blue California joins with the innovative Massachusetts-based biotech company Conagen to announce the commercialization of high-purity, fermentation-derived nicotinamide mononucleotide (NMN). A nature-based metabolic component which has caught the attention of health-conscious consumers for supporting energy and longevity.
The quest to age healthily and support longevity is surging among health-conscious consumers. “Consumers are reassessing their dietary regimen to make room for ingredients that can support an increased healthspan,” said Chief Science Officer at Blue California, Dr. Priscilla Samuel.
NMN supplements are highly sought-after for healthy aging applications, including brain health, vitality, heart health, metabolic health, and even cosmetics. However, current NMN ingredients used in products on the market are mostly produced by chemical synthesis.
While consumers are exploring dietary supplements for a holistic approach to health, they are also demanding clean labels from their supplements, and moving away from synthetic ingredients. Blue California’s fermentation-derived NMN opens new opportunities for producers to consider consumers' health more holistically while acquiring a closer-to-nature position.
NMN serves as a precursor to nicotinamide adenine dinucleotide (NAD+), a coenzyme present in all living cells and critical for mitochondrial function.
Increased intracellular levels of NAD+ boost energy production and improve cellular health, but levels decline dramatically with age. Replenishing NAD+ in the body with its precursor NMN has been proposed as a way to possibly combat age-related degeneration and increase healthy lifespan.
“Our fermentation-derived offering is well-positioned to capitalize on the growing recognition of NMN as an important ingredient in the food and supplement spaces,” said Samuel. “NMN is a well-known molecule in the longevity research community, and emerging research also suggests potential applications for immune health as well as sports nutrition.”
Harvard professor David Sinclair, a well-recognized leader in the field of aging research, is an advocate of NMN for improving the health of aging populations.
“NMN is a logical extension to our line of “longevity ingredients” which includes ergothioneine and pyrroloquinoline quinone. All of these molecules are made by our own proprietary fermentation processes, enabling our customers to better serve consumers who might reject chemically-derived ingredients,” said VP of Innovation at Conagen, Dr. Casey Lippmeier. “Because of the way we make it, Conagen’s NMN is of the highest purity and quality. It is also very cost-effective and compatible with clean-label trends, all of which demonstrates our strength as a strategic partner with Blue California.”
As innovation in dietary supplemental nutrition advances, so does the growth of global vitamin, mineral and supplement (VMS) launches. Mintel reported a growth of 67% of global VMS launches in Apr 2020 - Mar 2021, as compared to Apr 2016 - Mar 2017 --- where the United States leads the VMS market.
Blue California is a vertically integrated technology company providing innovative ingredient solutions to global partners. With more than 20 years of innovation success, our ingredients are used in commercial products and applications in the industries of nutrition, personal care, healthy aging and wellness, functional food and beverage, and beauty. www.bluecal-ingredients.com
Conagen is making the impossible possible. Our scientists and engineers use the latest synthetic biology tools to develop high-quality sustainable nature-based products through systems of manufacturing on a molecular level and fermentation basis. We focus on the bioproduction of high-value ingredients for food, nutrition, flavors and fragrances, pharmaceutical, and renewable materials industries. www.conagen.com
AttachmentTo view this piece of content from www.globenewswire.com, please give your consent at the top of this page.
To view this piece of content from ml.globenewswire.com, please give your consent at the top of this page.
One Liberty Plaza - 165 Broadway
NY 10006 New York
GlobeNewswire is one of the world's largest newswire distribution networks, specializing in the delivery of corporate press releases financial disclosures and multimedia content to the media, investment community, individual investors and the general public.
Subscribe to releases from GlobeNewswire
Subscribe to all the latest releases from GlobeNewswire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from GlobeNewswire
Only 3% of Financial Services Firms Ready for Open Banking Deadline28.7.2021 07:00:00 CEST | Press release
Data Privacy Challenges Blocking Open Banking Adoption for Business Growth, Innovation LONDON, July 28, 2021 (GLOBE NEWSWIRE) -- Only 3% of financial services (FS) organisations are confident they are prepared for the next major Open Banking enforcement deadline, due in September 2021, according to new research from Delphix, the industry leading data company for DevOps. The study – carried out by Pulse and commissioned by Delphix – polled 100 tech leaders in the finance banking and insurance industry to understand how prepared they are for compliance with Open Banking deadlines and what’s getting in the way. All respondents are from EMEA (77%) and APAC (23%) and work at companies with over 10,000 employees. Despite the Second Payments Services Directive (PSD2) and Strong Customer Authentication (SCA) requirement, which were initially slated to take effect September 2019, and then delayed by two years, the majority of FS organisations are still not ready. In fact, according to the poll,
Hexagon Composites ASA: Invitation to presentation of second quarter and half- year results 202128.7.2021 07:00:00 CEST | Press release
Hexagon Composites ASA’s second quarter and half-year results 2021 will be released on 12 August 2021, 07:00 CET. Jon Erik Engeset (CEO) and David Bandele (CFO) will present the results at 08:30 CEST and the presentation will be broadcasted live via https://hexagongroup.kg5.no/ The presentation will be held in English. A recording of the presentation will be made available on www.hexagongroup.com after the presentation. For more information: Hiva Ghiri, VP Investor Relations, Hexagon Composites Telephone: +47 958 66 790 | email@example.com Karen Romer, SVP Communications, Hexagon Composites Telephone: +47 950 74 950 | firstname.lastname@example.org About Hexagon Composites ASA Hexagon delivers safe and innovative solutions for a cleaner energy future. Our solutions enable storage, transportation, and conversion to clean energy in a wide range of mobility, industrial and consumer applications. Learn more at www.hexagongroup.com and follow @HexagonASA on Twitter and LinkedIn This
Idorsia launches the offering of convertible bonds to fund the development of the company into a leading biopharmaceutical company28.7.2021 07:00:00 CEST | Press release
Ad hoc announcement pursuant to Art. 53 LR NOT FOR RELEASE, PUBLICATION, DISTRIBUTION IN OR INTO THE UNITED STATES, AUSTRALIA, JAPAN OR ANY OTHER JURISDICTION IN WHICH SUCH RELEASE, PUBLICATION OR DISTRIBUTION WOULD BE PROHIBITED BY APPLICABLE LAWS. This announcement is not a prospectus and not an offer of securities for sale in any jurisdiction, including in or into the United States, Japan, Australia or South Africa Idorsia launches the offering of approx. CHF 600 million convertible bonds Allschwil, Switzerland – July 28, 2021 Idorsia Ltd (SIX: IDIA, “Idorsia”) today announced the launch of approx. CHF 600 million senior unsecured convertible bonds (the “Bonds”) due 2028 convertible into shares of Idorsia (the “Shares”). The net proceeds from the offering will be used to support commercial product launches in several key markets in 2022 (pending regulatory approval) and to fund the further development of the company’s advancing late-stage pipeline. Idorsia’s main shareholders, Jean-
Hexagon Purus ASA: Invitation to presentation of second quarter and half- year results 202128.7.2021 07:00:00 CEST | Press release
Hexagon Purus ASA’s second quarter and half-year results 2021 will be released on 10 August 2021, 07:00 CEST. Morten Holum (CEO) and Dilip Warrier (CFO) will present the results at 08:30 CEST and the presentation will be broadcasted live via https://hexagonpurus.kg5.no/ The presentation will be held in English. A recording of the presentation will be made available on www.hexagonpurus.com after the presentation. For more information: Salman Alam, Vice President, Corporate Development, Hexagon Purus ASA Telephone: +47 476 12 713 | email@example.com Dilip Warrier, CFO, Hexagon Purus ASA Telephone: +1 949-236-5528 | firstname.lastname@example.org About Hexagon Purus ASA Hexagon Purus, a Hexagon Composites company, is a world leading provider of hydrogen type 4 high-pressure cylinders, battery packs and vehicle systems integration for fuel cell electric and battery electric vehicles. Hexagon Purus enables zero emission solutions for light, medium and heavy-duty vehicles, buses,
Equinor introduserer første transje av program for tilbakekjøp av aksjer28.7.2021 06:46:00 CEST | Pressemelding
Equinor (OSE: EQNR, NYSE: EQNR) starter i dag første transje på om lag 300 millioner dollar av programmet for tilbakekjøp av aksjer, som ble kunngjort på kapitalmarkedsdagen 15. juni 2021. På kapitalmarkedsdagen kunngjorde Equinor en konkurransedyktig kapitaldistribusjon med en økning av det kvartalsvise kontantutbytte til 18 cent per aksje og oppstart av et nytt program for tilbakekjøp av aksjer, noe som gir en kapitaldistribusjonsstruktur med økt fleksibilitet. Første transje av tilbakekjøpsprogrammet er på inntil 300 millioner USD, inkludert aksjer som innløses fra den norske stat, og vil avsluttes senest 28. september 2021. For 2021 forventes programmet for tilbakekjøp av aksjer å utgjøre om lag 600 millioner USD, inkludert aksjer som innløses fra den norske stat. Fra 2022 forventes et årlig tilbakekjøpsprogram på om lag 1,2 milliarder USD å bli gjennomført når prisen på Brent-olje er i, eller over, prisnivået 50-60 USD/fat, Equinors netto gjeldsgrad(1) holder seg innenfor ambisjon
Equinor commences first tranche in share buy-back programme28.7.2021 06:46:00 CEST | Press release
Equinor (OSE: EQNR, NYSE: EQNR) today commences the first tranche of around USD 300 million, of the new share buy-back programme announced at the Capital Markets Day on 15 June 2021. At the Capital Markets Day Equinor announced a competitive capital distribution with an increase of the quarterly cash dividend to 18 cents per share and the start of a new share buy-back programme, providing a capital distribution structure with increased flexibility. The first tranche of the share buy-back programme is up to USD 300 million, including shares to be redeemed from the Norwegian State, and will end no later than 28 September 2021. For 2021 the share buy-back programme is expected at USD 600 million, including shares to be redeemed from the Norwegian State. Starting in 2022 the annual share buy-back programme of around USD 1.2 billion is expected to be executed when Brent oil prices are in or above the range of 50-60 USD/bbl, Equinor’s net debt ratio(1) stays within the communicated ambition
Equinor ASA: Information relating to dividend for second quarter 202128.7.2021 06:45:00 CEST | Press release
Key information relating to the cash dividend to be paid by Equinor (OSE: EQNR, NYSE: EQNR) for second quarter 2021. Dividend amount: 0.18 Declared currency: USD Last day including rights New York Stock Exchange (NYSE): 9 November 2021 Ex-date NYSE: 10 November 2021 Last day including rights Oslo Børs (Oslo Stock Exchange): 10 November 2021 Ex-date Oslo Børs: 11 November 2021 Record date NYSE and Oslo Børs: 12 November 2021 Payment date: 24 November 2021 Other information: Dividend per share in NOK will be communicated 18 November 2021. This information is published in accordance with the requirements of the Continuing Obligations. This information is subject to the disclosure requirements pursuant to Section 5-12 in the Norwegian Securities Trading Act